Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2
- PMID: 16551619
- DOI: 10.1074/jbc.M513737200
Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2
Abstract
The transcription factor Nrf2 (nuclear factor E2-related factor 2) regulates the expression of antioxidant phase II genes and contributes to preserve redox homeostasis and cell viability in response to oxidant insults. Nrf2 should be coordinated with the canonical cell survival pathway represented by phosphatidylinositol 3-kinase (PI3K) and the Ser/Thr kinase Akt but so far the mechanistic connections remain undefined. Here we identify glycogen synthase kinase-3beta (GSK-3beta), which is inhibited by Akt-mediated phosphorylation, as the link between both processes. Using heme oxygenase-1 (HO-1) as a model phase II gene, we found that both PI3K and Akt increased mRNA and protein levels of this enzyme. Pharmacological inhibitors (LiCl and PDZD-8) and genetic variants of GSK-3beta (constitutively active and dominant negative mutants) indicated that PI3K/Akt activates and GSK-3beta inhibits the antioxidant response elements of the ho1 promoter and pointed Nrf2 as directly involved in this process. Indeed, GSK-3beta phosphorylated Nrf2 in vitro and in vivo. Immunocytochemistry and subcellular fractionation analyses demonstrated that the effect of GSK-3beta-mediated phosphorylation of Nrf2 is to exclude this transcription factor from the nucleus. Nrf2 up-regulated the expression of HO-1, glutathione peroxidase, glutathione S-transferase A1, NAD(P)H: quinone oxidoreductase and glutamate-cysteine ligase and protected against hydrogen peroxide-induced glutathione depletion and cell death, whereas co-expression of active GSK-3beta attenuated both phase II gene expression and oxidant protection. These results contribute to clarify the cross-talk between the survival signal elicited by PI3K/Akt and the antioxidant phase II cell response, and introduce GSK-3beta as the key mediator of this regulation mechanism.
Similar articles
-
GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress.J Neurochem. 2008 Apr;105(1):192-202. doi: 10.1111/j.1471-4159.2007.05124.x. Epub 2007 Nov 13. J Neurochem. 2008. PMID: 18005231
-
The Cytoprotective Effect of Hyperoside against Oxidative Stress Is Mediated by the Nrf2-ARE Signaling Pathway through GSK-3β Inactivation.PLoS One. 2015 Dec 16;10(12):e0145183. doi: 10.1371/journal.pone.0145183. eCollection 2015. PLoS One. 2015. PMID: 26674355 Free PMC article.
-
Farrerol Directly Targets GSK-3β to Activate Nrf2-ARE Pathway and Protect EA.hy926 Cells against Oxidative Stress-Induced Injuries.Oxid Med Cell Longev. 2020 Jan 28;2020:5967434. doi: 10.1155/2020/5967434. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32082480 Free PMC article.
-
Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of β-TrCP and GSK-3.Biochem Soc Trans. 2015 Aug;43(4):611-20. doi: 10.1042/BST20150011. Epub 2015 Aug 3. Biochem Soc Trans. 2015. PMID: 26551701 Review.
-
GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders.Pharmacol Rep. 2022 Aug;74(4):557-569. doi: 10.1007/s43440-022-00390-z. Epub 2022 Jul 26. Pharmacol Rep. 2022. PMID: 35882765 Review.
Cited by
-
Daidzein's potential in halting neurodegeneration: unveiling mechanistic insights.Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug 19. doi: 10.1007/s00210-024-03356-5. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39158734 Review.
-
Ferroptosis regulation by Cap'n'collar family transcription factors.J Biol Chem. 2024 Aug;300(8):107583. doi: 10.1016/j.jbc.2024.107583. Epub 2024 Jul 16. J Biol Chem. 2024. PMID: 39025451 Free PMC article. Review.
-
Ecklonia cava Polyphenols Have a Preventive Effect on Parkinson's Disease through the Activation of the Nrf2-ARE Pathway.Nutrients. 2024 Jun 28;16(13):2076. doi: 10.3390/nu16132076. Nutrients. 2024. PMID: 38999824 Free PMC article.
-
PPARγ alleviates preeclampsia development by regulating lipid metabolism and ferroptosis.Commun Biol. 2024 Apr 9;7(1):429. doi: 10.1038/s42003-024-06063-2. Commun Biol. 2024. PMID: 38594496 Free PMC article.
-
Simvastatin-Mediated Nrf2 Activation Induces Fetal Hemoglobin and Antioxidant Enzyme Expression to Ameliorate the Phenotype of Sickle Cell Disease.Antioxidants (Basel). 2024 Mar 11;13(3):337. doi: 10.3390/antiox13030337. Antioxidants (Basel). 2024. PMID: 38539870 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous